High rate of insomnia during early recovery from addiction

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery, says review in Journal of Addiction Medicine

2014-11-05

(Press-News.org) November 5, 2014 – Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

"Treating sleep disturbance in early recovery may have considerable impact on maintenance of sobriety and quality of life," according to Dr Nicholas Rosenlicht of University of San Francisco and colleagues. They summarize the benefits of treatment, highlighting the role of effective behavioral approaches. The lead author was Katherine A. Kaplan, PhD, of Stanford University School of Medicine.

High Rate and Impact of Insomnia during Early Recovery Dr Rosenlicht and coauthors cite evidence suggesting that the incidence of insomnia in early recovery may be five times higher than the general population and may persist for months to years.

Insomnia may be linked with a higher risk of alcohol-related problems and relapse. The association may run in the other direction as well—population studies report people with sleep disturbance are more likely to be at risk of developing addiction..

Compounding the problem, some patients addicted to alcohol use the substance in the evening in an effort to address sleep problems. Alcohol is a well-documented cause of sleep disruption with toxic effects on several neurobiological systems, and may contribute to lasting sleep problems even during abstinence.

If insomnia contributes to relapse, can treatment for insomnia reduce that risk? The evidence is mixed, with some studies reporting that using medications for insomnia during recovery (mainly from addiction with alcohol) can lower the relapse rate.

Clinicians should be cautious when prescribing medications to address insomnia in the recovering patient. This population of patients may be at increased risk for misuse, abuse, or addiction to sleep medications, or prone to "rebound insomnia" after medications are discontinued. In short, use of such medications may increase the risk of relapse.

Evidence Supports Behavioral Treatments More generally, clinicians should be aware prescribing medications to treat insomnia may be "incongruent with or unpalatable to" treatment programs focusing on abstinence. In one survey, many addiction medicine specialists said they'd be reluctant to prescribe any medication to patients with sleep problems.

This belief has made behavioral approaches more widely used to treat patients with insomnia during recovery. In particular, evidence supports the use of cognitive-behavioral therapy (CBT). This multicomponent approach includes daily sleep diaries and questionnaires to gather information on the patient's insomnia and progress during treatment; and education on sleep and the effects of substances, including "sleep hygiene" practices to promote good sleep.

CBT intervenes by targeting processes that perpetuate insomnia. Behavioral interventions include sleep restriction, limiting time in bed to the actual amount of time slept; and stimulus control, seeking to strengthen the association between being in bed and sleeping. Patients also receive cognitive interventions, challenging negative or catastrophic thoughts about the consequences of insomnia.

"Treatment of insomnia after abstinence represents an important treatment target and an integral part of any recovery plan," Dr Rosenlicht and coauthors conclude. They note the critical need for more research on treatment of insomnia during early recovery with a focus upon understanding if r CBT lowers relapse risk. The review is accompanied by a clinical case discussion about effective use of behavioral treatment in a veteran with alcohol dependence with insomnia.

INFORMATION: Click here to read "An Evidence-Based Review of Insomnia Treatment in Early Recovery."

Click here to read "Behavioral Treatment of Insomnia in Early Recovery."

About Journal of Addiction Medicine The mission of Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical specialty. Published quarterly, the Journal is designed for all physicians and other mental health professionals who need to keep up-to-date with the treatment of addiction disorders. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics.

About The American Society of Addiction Medicine The American Society of Addiction Medicine is a national medical specialty society of over 3,200 physicians and associated health professionals. Its mission is to increase access to and improve the quality of addiction treatment, to educate physicians, and other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of patients with addictive disorders, and to establish addiction medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care services and the general public. ASAM was founded in 1954, and has had a seat in the American Medical Association House of Delegates since 1988. Follow ASAM's official Twitter handle: @ASAMorg

About Wolters Kluwer Health Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth.

ELSE PRESS RELEASES FROM THIS DATE:

Betting on brain research

2014-11-05

Despite great advances in understanding how the human brain works, psychiatric conditions, neurodegenerative disorders, and brain injuries are on the rise. Progress in the development of new diagnostic and treatment approaches appears to have stalled. In a special issue of the Cell Press journal Neuron, experts look at the challenges associated with "translational neuroscience," or efforts to bring advances in the lab to the patients who need them. "A variety of global impact studies have identified brain disorders as a leading contributor to disabilities and morbidity ...

Risk stratification model may aid in lung cancer staging and treatment decisions

2014-11-05

DENVER – A risk stratification model based on lymph node characteristics confirms with a high level of confidence the true lack of lung cancer in lymph nodes adequately sampled with endobronchial ultrasound-guided transbronchial needle aspiration and classified as negative. Lung cancer treatment and prognosis is critically dependent on accurate staging that takes into account the extent to which cancer has spread from the primary lung tumor to other locations. Examination of lymph nodes containing lung cancer cells that have spread can be done by surgical removal, ...

Retinal-scan analysis can predict advance of macular degeneration, Stanford study finds

2014-11-05

Stanford University School of Medicine scientists have found a new way to forecast which patients with age-related macular degeneration are likely to suffer from the most debilitating form of the disease. The new method predicts, on a personalized basis, which patients' AMD would, if untreated, probably make them blind, and roughly when this would occur. Simply by crunching imaging data that is already commonly collected in eye doctors' offices, ophthalmologists could make smarter decisions about when to schedule an individual patient's next office visit in order to optimize ...

NASA's TRMM and GPM satellites analyze Hurricane Vance before landfall

2014-11-05

Hurricane Vance was a hurricane on Nov. 4 when the Tropical Rainfall Measuring Mission or TRMM satellite and the Global Precipitation Measurement (GPM) mission satellite passed overhead and measured its rainfall from space. TRMM and GPM revealed areas of heavy rain within the storm before it weakened to a depression and made landfall on Nov. 5. The TRMM satellite flew over hurricane Vance on Nov. 4 at 0953 UTC (4:53 a.m. EST). Rainfall derived from TRMM's Microwave Imager (TMI) data collected were overlaid on a 1000 UTC (5 a.m. EST) image from NOAA's GOES-West satellite ...

NASA sees Typhoon Nuri pass Iwo To, Japan

2014-11-05

Typhoon Nuri continued moving in a northeasterly direction passing the island of Iwo To, Japan when NASA's Aqua satellite passed overhead. The Moderate Resolution Imaging Spectroradiometer or MODIS instrument that flies aboard NASA's Aqua satellite captured a visible picture of Typhoon Nuri on Nov. 5 at 4:10 UTC (11:10 p.m. EST, Nov. 4). At 1002 UTC (5:02 a.m. EST) a microwave image captured from NASA/JAXA's Tropical Rainfall Measuring Mission or TRMM satellite showed that the low-level center of circulation was beginning to weaken. The strongest thunderstorms had become ...

Interstitial lung disease is a significant risk factor for lung inflammation following stereotactic body radiation therapy for lung cancer

2014-11-05

DENVER – Pretreatment interstitial lung disease (ILD) is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT) alone. ILD is a group of diseases that cause scarring and stiffing of the tissue and space around the air sacs in the lungs, which results in diminished gas exchange. The incidence of ILD among lung cancer patients is higher than in the general population as tobacco smoking is a common risk factor for both. Some ...

Shape of things to come in platelet mimicry

2014-11-05

CLEVELAND—Artificial platelet mimics developed by a research team from Case Western Reserve University and University of California, Santa Barbara, are able to halt bleeding in mouse models 65 percent faster than nature can on its own. For the first time, the researchers have been able to integratively mimic the shape, size, flexibility and surface chemistry of real blood platelets on albumin-based particle platforms. The researchers believe these four design factors together are important in inducing clots to form faster selectively at vascular injury sites while ...

EARTH Magazine: Tiny ants are heroic weathering agents

2014-11-05

Alexandria, Va. — Earth's abundant silicate minerals are degraded over time by exposure to water, chemical dissolution, and physical and chemical weathering by tree roots and even insects such as ants and termites. Such weathering plays a significant role in decreasing carbon dioxide in the atmosphere, as carbon dioxide is consumed in chemical weathering reactions and the resultant carbonate becomes sequestered in the form of limestone and dolomite. To study the effects of weathering over time, researchers buried basalt sand at multiple test sites and dug up the ...

Can love make us mean?

2014-11-05

BUFFALO, N.Y. – Empathy is among humanity's defining characteristics. Understanding another person's plight can inspire gentle emotions and encourage nurturing behaviors. Yet under certain circumstances, feelings of warmth, tenderness and sympathy can in fact predict aggressive behaviors, according to a recent study by two University at Buffalo researchers. But why? That an expression of kindness might be manifest as a punch in the nose can leave observers scratching their heads. The answer is that it's not about anger or feeling personally threatened, says ...

New e-Incubator enables real-time imaging of bioengineered tissues in controlled unit

2014-11-05

"New Rochelle, NY, November 5, 2014—The e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under controlled conditions and to study their growth and development in real-time without risk of contamination or damage. Offering the potential to test engineered tissues before human transplantation, increase the success rate of implantation, and accelerate the translation of tissue engineering methods from the lab to the clinic, the novel e-incubator is described ...